Results 91 to 100 of about 149,298 (164)

Personalized Cancer Vaccines in the Clinical Trial Pipeline. [PDF]

Asia Pac J Clin Oncol
Iamukova L, Alferova E.
europepmc   +1 more source

mRNA Cancer Vaccines: From Pandemic Paradigm to Personalized Oncology Therapeutics. [PDF]

Cancer Innov
Yang B, Liu J, Li Y, Liu X.
europepmc   +1 more source

Personalized cancer vaccines: promise, challenges, and the path forward. [PDF]

Ann Med Surg (Lond)
Shafique M, Chaman Lal K, Ahmed MF.
europepmc   +1 more source

Key Clinical Frontiers of mRNA Loaded Lipid Nanoparticles in Cancer Vaccines. [PDF]

Int J Nanomedicine
Cao L, Min J, Yu M, Zhang Z, Yuan D, Chen D.   +5 more
europepmc   +1 more source

Engineering Anti-Tumor Immunity: An Immunological Framework for mRNA Cancer Vaccines. [PDF]

Vaccines (Basel)
Roy O, Anderson KS.
europepmc   +1 more source

Personalized and HPV cancer vaccines in head and neck squamous cell carcinoma: from concept to clinical implementation. [PDF]

Transl Oncol
Filippini DM, Le Tourneau C.
europepmc   +1 more source

Minimalist mRNAs: A fast track to cancer vaccines. [PDF]

Mol Ther Nucleic Acids
Salaberry L, Covo-Vergara Á, Beloki U, Silva-Pilipich N, Smerdou C.   +4 more
europepmc   +1 more source

Editorial: Advancements in antibody-based immunotherapy and cancer vaccines for hepatocellular carcinoma. [PDF]

Front Immunol
Tabll AA, Saeed A, Elkafrawy MS, El-Kafrawy SA.   +3 more
europepmc   +1 more source

Advances and Strategies in Enhancing mRNA Cancer Vaccines. [PDF]

Adv Mater
Zhang M, Chen S, Hu H, Ong Y, Ni Q.
europepmc   +1 more source